Matches in SemOpenAlex for { <https://semopenalex.org/work/W2405697890> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W2405697890 endingPage "e9" @default.
- W2405697890 startingPage "e5" @default.
- W2405697890 abstract "Les stries angioïdes sont une pathologie oculaire qui se complique fréquemment par la survenue de néovaisseaux choroïdiens. Leur prise en charge a longtemps été dominée par des traitements conventionnels tels le laser thermique ou la photothérapie dynamique. Plus récemment, les anti-VEGF sont devenus une alternative thérapeutique de choix. Nous rapportons le cas d’un patient de 54 ans ayant présenté des néovaisseaux choroïdiens en rapport avec la présence de stries angioïdes et pour lesquels un traitement par anti-VEGF (ranibizumab) a été réalisé. Deux injections ont été nécessaires pour stopper le processus néovasculaire. Le patient a été suivi pendant plus de 12 mois sans qu’aucune récidive ne soit notée. Ce cas illustre l’intérêt des anti-VEGF dans la prise en charge des néovaisseaux choroïdiens compliquant les stries angioïdes. Des études prospectives et randomisées incluant un plus grand nombre de patients sont nécessaires afin d’établir le rythme d’injections et de surveillance optimal dans cette pathologie. Angioid streaks are biomicroscopically observable manifestations that frequently lead to choroidal neovascularization. Traditional treatments used to include laser photocoagulation or photodynamic therapy. Over the past few years, anti-VEGF therapies have been used as an alternative treatment. The case of a 54-year-old patient who received anti-VEGF therapy (ranibizumab) for the treatment of choroidal neovascularization secondary to angioid streaks is reported. The patient received two injections that led to complete resolution of intraretinal fluid and reduction in lesion size. After 1 year of follow-up, the patient has presented no recurrence. This case illustrates the efficacy of intravitreal anti-VEGF therapy for choroidal neovascularization in angioid streaks. Further prospective studies on a larger number of patients should help establish the best treatment and follow-up strategies." @default.
- W2405697890 created "2016-06-24" @default.
- W2405697890 creator A5004135592 @default.
- W2405697890 creator A5055829463 @default.
- W2405697890 creator A5061836464 @default.
- W2405697890 creator A5064730042 @default.
- W2405697890 creator A5072482843 @default.
- W2405697890 creator A5083982156 @default.
- W2405697890 date "2013-01-01" @default.
- W2405697890 modified "2023-09-28" @default.
- W2405697890 title "Traitement par injection intravitréenne de ranibizumab de néovaisseaux choroïdiens compliquant des stries angioïdes : à propos d’un cas" @default.
- W2405697890 cites W170558594 @default.
- W2405697890 cites W1969129019 @default.
- W2405697890 cites W1970142574 @default.
- W2405697890 cites W1972405911 @default.
- W2405697890 cites W1995078360 @default.
- W2405697890 cites W2019553690 @default.
- W2405697890 cites W2023821993 @default.
- W2405697890 cites W2035679927 @default.
- W2405697890 cites W2045275571 @default.
- W2405697890 cites W2056293400 @default.
- W2405697890 cites W2092201615 @default.
- W2405697890 cites W2144303941 @default.
- W2405697890 cites W2164200654 @default.
- W2405697890 doi "https://doi.org/10.1016/j.jfo.2012.04.004" @default.
- W2405697890 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23306178" @default.
- W2405697890 hasPublicationYear "2013" @default.
- W2405697890 type Work @default.
- W2405697890 sameAs 2405697890 @default.
- W2405697890 citedByCount "1" @default.
- W2405697890 countsByYear W24056978902017 @default.
- W2405697890 crossrefType "journal-article" @default.
- W2405697890 hasAuthorship W2405697890A5004135592 @default.
- W2405697890 hasAuthorship W2405697890A5055829463 @default.
- W2405697890 hasAuthorship W2405697890A5061836464 @default.
- W2405697890 hasAuthorship W2405697890A5064730042 @default.
- W2405697890 hasAuthorship W2405697890A5072482843 @default.
- W2405697890 hasAuthorship W2405697890A5083982156 @default.
- W2405697890 hasConcept C118487528 @default.
- W2405697890 hasConcept C141071460 @default.
- W2405697890 hasConcept C2776694085 @default.
- W2405697890 hasConcept C2777802072 @default.
- W2405697890 hasConcept C2778784831 @default.
- W2405697890 hasConcept C2780827179 @default.
- W2405697890 hasConcept C2781100027 @default.
- W2405697890 hasConcept C2781359195 @default.
- W2405697890 hasConcept C71924100 @default.
- W2405697890 hasConceptScore W2405697890C118487528 @default.
- W2405697890 hasConceptScore W2405697890C141071460 @default.
- W2405697890 hasConceptScore W2405697890C2776694085 @default.
- W2405697890 hasConceptScore W2405697890C2777802072 @default.
- W2405697890 hasConceptScore W2405697890C2778784831 @default.
- W2405697890 hasConceptScore W2405697890C2780827179 @default.
- W2405697890 hasConceptScore W2405697890C2781100027 @default.
- W2405697890 hasConceptScore W2405697890C2781359195 @default.
- W2405697890 hasConceptScore W2405697890C71924100 @default.
- W2405697890 hasIssue "1" @default.
- W2405697890 hasLocation W24056978901 @default.
- W2405697890 hasLocation W24056978902 @default.
- W2405697890 hasOpenAccess W2405697890 @default.
- W2405697890 hasPrimaryLocation W24056978901 @default.
- W2405697890 hasRelatedWork W1987334421 @default.
- W2405697890 hasRelatedWork W2017251892 @default.
- W2405697890 hasRelatedWork W2089561855 @default.
- W2405697890 hasRelatedWork W2099511225 @default.
- W2405697890 hasRelatedWork W2108500051 @default.
- W2405697890 hasRelatedWork W2164434374 @default.
- W2405697890 hasRelatedWork W2497759374 @default.
- W2405697890 hasRelatedWork W2740481951 @default.
- W2405697890 hasRelatedWork W4318051922 @default.
- W2405697890 hasRelatedWork W796305812 @default.
- W2405697890 hasVolume "36" @default.
- W2405697890 isParatext "false" @default.
- W2405697890 isRetracted "false" @default.
- W2405697890 magId "2405697890" @default.
- W2405697890 workType "article" @default.